Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director · Executive Chairman · 10% owner | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 100,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 100,000 · Balance 100,000 F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2026 Filed Jan 23, 2026 22:03 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021239 · ownership.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 34,375 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001193125-25-314329 · ownership.xml · derivative · entry 2 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 34,375 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 25, 2016 and are fully vested. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 34,375 | $25.52 | $877,250.00 |
DisclosureSEC source: 0001193125-25-314329 · ownership.xml · nonDerivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 23:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 75,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047036 · ownership.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 21:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 26,042 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0000950170-24-129270 · ownership.xml · derivative · entry 2 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 26,042 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on January 20, 2015 and are fully vested. Read SEC document |
| November 15, 2024 Filed Nov 20, 2024 21:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 26,042 | $24.10 | $627,612.20 |
DisclosureSEC source: 0000950170-24-129270 · ownership.xml · nonDerivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:33 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 75,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008878 · ownership.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass B Common Stock · Derivative | 171,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 3 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By The Sonali Paul Children's Irrevocable Trust Disclosed balance after: 171,100 Underlying: Class A Common Stock · 171,100 shares Expires not disclosed F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children. F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass B Common Stock · Derivative | 171,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 2 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By The David C. Paul Children's Trust Disclosed balance after: 171,100 Underlying: Class A Common Stock · 171,100 shares Expires not disclosed F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children. F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F3 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GiftClass B Common Stock · Derivative | 342,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-068856 · ownership.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,525,324 Underlying: Class A Common Stock · 342,200 shares Expires not disclosed F1 · derivative.exercise_price: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F2 · kind: This transaction involved a gift by the reporting person and his spouse of a total of 342,200 shares of Class B Common Stock to trusts for the benefit of their children. F1 · derivative.exercise_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F1 · derivative.expiration_date: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:50 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 75,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013213 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 75,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005571 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Class A Common Stock · 75,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004030 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004841 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 22, 2019 Filed Feb 11, 2019 21:44 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001209191-19-008984 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2029-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass B Common Stock · Derivative | 748,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 13 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,867,524 Underlying: Class A Common Stock · 748,845 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 748,845 | $54.70 | $40,959,125.66 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 9 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $55.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass A Common Stock | 748,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 8 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass B Common Stock · Derivative | 101,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 12 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,616,369 Underlying: Class A Common Stock · 101,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass B Common Stock · Derivative | 298,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 11 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Sonali Paul Children's Trust Disclosed balance after: 0 Underlying: Class A Common Stock · 298,647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass B Common Stock · Derivative | 298,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · derivative · entry 10 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By David C. Paul Children's Trust Disclosed balance after: 0 Underlying: Class A Common Stock · 298,647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock. F3 · derivative.exercise_price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · shares: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.exercise_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F3 · derivative.expiration_date: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 101,320 | $54.01 | $5,472,556.63 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 7 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass A Common Stock | 101,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 6 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 298,647 | $54.01 | $16,130,700.95 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 5 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Sonali Paul Children's Trust Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass A Common Stock | 298,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 4 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Sonali Paul Children's Trust Disclosed balance after: 298,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F5 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 298,647 | $54.01 | $16,130,700.95 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 3 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By David C. Paul Children's Trust Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | ConversionClass A Common Stock | 298,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 2 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By David C. Paul Children's Trust Disclosed balance after: 298,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date. F4 · ownership.nature: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:15 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 605,871 | $54.01 | $32,724,667.97 |
DisclosureSEC source: 0001209191-18-052374 · doc4.xml · nonDerivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 17, 2018 Filed Jul 20, 2018 00:16 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 6,841 | $52.95 | $362,230.95 |
DisclosureSEC source: 0001209191-18-043403 · doc4.xml · nonDerivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,871 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| April 30, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 72,938 | $51.81 | $3,778,574.97 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 21 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,712 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.935, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| April 27, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 29,066 | $51.78 | $1,505,127.58 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 20 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685,650 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $51.8558, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 43,750 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 30 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,250 Underlying: Class A Common Stock · 43,750 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 40,625 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 29 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,375 Underlying: Class A Common Stock · 40,625 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 98,958 | $0.00 Strike: $24.10 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 28 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,042 Underlying: Class A Common Stock · 98,958 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 60,000 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 27 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 60,000 shares Expires 2024-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: These options were granted on January 23, 2014, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 48,000 | $0.00 Strike: $13.04 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 26 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 48,000 shares Expires 2023-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $15.34 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 25 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,000 shares Expires 2022-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on August 29, 2012, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 18,461 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 24 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,461 shares Expires 2021-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on October 27, 2011, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 18,461 | $0.00 Strike: $11.86 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 23 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,461 shares Expires 2020-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 18,461 | $0.00 Strike: $4.88 | $0.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · derivative · entry 22 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 18,461 shares Expires 2019-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 363,284 | $51.81 | $18,820,581.53 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 19 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,716 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 43,750 | $51.81 | $2,266,547.50 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 18 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 43,750 | $26.27 | $1,149,312.50 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 17 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 40,625 | $51.81 | $2,104,651.25 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 16 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 40,625 | $25.52 | $1,036,750.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 15 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 98,958 | $51.81 | $5,126,697.31 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 14 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 98,958 | $24.10 | $2,384,887.80 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 13 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 60,000 | $51.81 | $3,108,408.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 12 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 60,000 | $23.95 | $1,437,000.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 11 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 48,000 | $51.81 | $2,486,726.40 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 10 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.